Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Endocrinology • Thyroid Disorders

Given the newer ATA guidelines, what is your approach to the management of Hurthle cell carcinoma?

Related Questions

Can carbamazepine make thyroid function test results look spuriously abnormal?

Would you consider extending Tepezza treatment for thyroid eye disease management in patients with incomplete response?

What are your thoughts on the possible correlation between Breast implants and thyroid autoimmune disorders / or thyroid cancer?

For patients with Hashimoto's thyroiditis, is there a commercially available blood test for detecting abnormalities in the type 1 deiodinase enzyme in order to identify patients who would potentially benefit from T4 and T3 combination therapy?

How do you counsel patients that are positive for both stimulatory and inhibitory autoimmune thyroid markers (TRAb, TSI and TPO Ab) regarding their likelihood of flipping from hyperthyroidism to hypothyroidism?

How do you approach the use of supraphysiologic T4 doses in patients with intermediate- and high-risk differentiated thyroid cancer, considering that elevated FT4 levels have not been linked to progression-free survival in recent clinical data?

What empiric dose change, if any, do you make for patients already taking liquid or softgel levothyroxine preconception upon confirmation of a positive pregnancy test?

Is it safe to discontinue prenatal vitamins that contain biotin for a few days during pregnancy when labs in particular thyroid tests are planned for treating hypo or hyperthyroidism in pregnancy?

Would you consider adding metformin to the regimen of a diabetic patient with a benign thyroid nodule to decrease its volume?

When, if ever, is it appropriate to switch from generic levothyroxine to brand name Synthroid?

Copyright © 2026 theMednet
All Rights Reserved.